Breyer Capital — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Atlas is a membership card and app that provides access to reservations at high-end restaurants, luxury hotels, sold-out concerts, and sporting events for members.
ConsumerDirect to ConsumerFintechSan Francisco, US
Patrick Mrozowski(Founder)inSid Parihar(Founder)Kenan Pulak(Founder)inClio Harper(Backend engineer intern)Andrew Harrington(Head of Operations)Sophie Jasinski(Senior Technical Recruiter)
Co-investors01 AdvisorsAccelARA NEA Ventures (Brand: Dmz.Xyz)Chapter OneEvolution VC PartnersFinancial Venture Studio+42 more
Collectible operates WatchCheck, a platform for luxury watch owners to service and care for their timepieces remotely, and partners with Sotheby's on watch servicing.
ConsumerE-commerceMarketplaces
Linden Lazarus(Co-Founder & CEO)inWill Haering(Co-Founder)in
Co-investorsColle Capital PartnersAPOLLO PROJECTSHyperguapSeven Seven SixShrug CapitalSpearhead+1 more
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Founder)inDr. David Suhy(Co-founder & Chief Scientific Officer)
BoardJustin Kao(Director)inJorge Conde(Director)in
Co-investorsAlumni VenturesAndreessen HorowitzBlue Ivy VenturesGaingelsHan River PartnersIKJ Capital+6 more
OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesBoston, US
Richard Gliklich, MD(Founder)Richard E. Gliklich(Executive Officer, Director)Richard Gliklich(Founder)
BoardRory O'Driscoll(Director)inLarry Bohn(Director)David Barrett(Director)
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystM33 GrowthScale Venture PartnersKaiser Permanente Ventures+1 more
Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Aaron Morris(Founder)inAlpha Lee(Chief Scientific Officer)inMatthew Robinson(Founder)inMatt Robinson(Founder)Milan Cvitkovic(ML Researcher)Ruby Pai(ML Researcher)
Co-investorsHOF CapitalLifeforce CapitalMetaplanetPioneerY CombinatorACE & Company+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














__Twitter.png)





.png)









